In summary, the advent of totally automated immunometric I-PTH assays has led to improved accurate clinical discrimination of parathyroid disorders and has provided a tool to measure PTH levels in real time during surgical procedures. Also, development of bioactive I-PTH assay provides more accurate assessment of secondary hyperparathyroidism in patients with end-stage renal disease and their need for vitamin D and/or calcium treatment.
< div class='tao-gold-member'>
Only gold members can continue reading. Log In or Register to continue
Related posts:
Origins and Innervations of Pharyngeal Arch and Somite Myotome Muscles
Effects of Bone Formation and Bone Resorption on Skeletal Mass
Clinical Guide to Vitamin D Measurement
Metaphyseal Chondrodysplasia, McKusick Type
Failure of Formation of Parts: Transverse Arrest (Continued)
Clinical Findings in Osteoarthritis
